The European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery: third report
Jazyk angličtina Země Německo Médium print
Typ dokumentu časopisecké články
PubMed
35150247
DOI
10.1093/ejcts/ezac032
PII: 6527516
Knihovny.cz E-zdroje
- Klíčová slova
- End-stage heart failure, Mechanical circulatory support, Registry, Ventricular assist device,
- MeSH
- dospělí MeSH
- hrudní chirurgické výkony * MeSH
- hrudní chirurgie * MeSH
- lidé MeSH
- podpůrné srdeční systémy * škodlivé účinky MeSH
- registrace MeSH
- srdeční selhání * chirurgie MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: In the third report of the European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery, outcomes of patients receiving mechanical circulatory support are reviewed in relation to implant era. METHODS: Procedures in adult patients (January 2011-June 2020) were included. Patients from centres with <60% follow-ups completed were excluded. Outcomes were stratified into 3 eras (2011-2013, 2014-2017 and 2018-2020). Adverse event rates (AERs) were calculated and stratified into early phase (<3 months) and late phase (>3 months). Risk factors for death were explored using univariable Cox regression with a stepwise time-varying hazard ratio (<3 vs >3 months). RESULTS: In total, 4834 procedures in 4486 individual patients (72 hospitals) were included, with a median follow-up of 1.1 (interquartile range: 0.3-2.6) years. The annual number of implants (range: 346-600) did not significantly change (P = 0.41). Both Interagency Registry for Mechanically Assisted Circulatory Support class (classes 4-7: 23, 25 and 33%; P < 0.001) and in-hospital deaths (18.5, 17.2 and 11.2; P < 0.001) decreased significantly between eras. Overall, mortality, transplants and the probability of weaning were 55, 25 and 2% at 5 years after the implant, respectively. Major infections were mainly noted early after the implant occurred (AER<3 months: 1.44 vs AER>3 months: 0.45). Bilirubin and creatinine levels were significant risk factors in the early phase but not in the late phase after the implant. CONCLUSIONS: In its 10 years of existence, EUROMACS has become a point of reference enabling benchmarking and outcome monitoring. Patient characteristics and outcomes changed between implant eras. In addition, both occurrence of outcomes and risk factor weights are time dependent.
Azienda Ospedaliera San Camillo Forlanini Rome Italy
Cardiothoracic Dept AHEPA University Hospital Aristotle University Thessaloniki Greece
Center for Cardiovascular Surgery and Transplantation Surgery Brno Brno Czech Republic
Clinica Universidad de Navarra Pamplona Spain
Department of Cardiothoracic and Vascular Surgery German Heart Center Berlin Berlin Germany
Department of Cardiovascular Surgery University Hospital Freiburg Freiburg Germany
DZHK Partner Site Berlin Germany
Ege University Hospital Izmir Turkey
ESPAMACS Sociedad Española de Cirugía Cardiovascular y Endovascular Madrid Spain
EUROMACS EACTS House Windsor UK
Heart Center of the Semmelweis University Budapest Hungary
Herz und Diabeteszentrum NRW Bad Oeynhausen Germany
HerzZentrum Hirslanden Zürich Switzerland
Herzzentrum Leipzig Leipzig Germany
Institute for Clinical and Experimental Medicine Prague Czech Republic
Katholieke Universiteit Leuven Leuven Belgium
Klinika Kardiochirurgie NUSCH Bratislava Slovakia
Leiden University Medical Center Leiden Netherlands
Medical Faculty of the Albert Ludwigs University Freiburg Germany
National Research Cardiac Surgery Center Astana Kazakhstan
Onassis Cardiac Surgery Center Athens Greece
Onze Lieve Vrouwenziekenhuis Aalst Belgium
Ospedale Papa Giovanni XIII Bergamo Italy
Prince Sultan Cardiac Center Al Hassa Saudi Arabia
Rigshospitalet Copenhagen Denmark
San Orsola Hospital Bologna Italy
Silesian Center for Heart Diseases Zabrze Poland
Thorax Center Department of Cardiology Erasmus University Medical Center Rotterdam Netherlands
Universitair Medisch Centrum Groningen Groningen Netherlands
Universitäres Herzzentrum Hamburg Hamburg Germany
Universitätskliniken Innsbruck Innsbruck Austria
Universitätsklinikum Köln AöR Köln Germany
University Hospital Bern Bern Switzerland
University Hospital Zürich Zürich Switzerland
Citace poskytuje Crossref.org